These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. De La Garza R; Mahoney JJ Brain Res; 2004 Sep; 1021(2):209-18. PubMed ID: 15342269 [TBL] [Abstract][Full Text] [Related]
7. Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression. Jeannotte AM; McCarthy JG; Redei EE; Sidhu A Neuropsychopharmacology; 2009 Mar; 34(4):987-98. PubMed ID: 18800064 [TBL] [Abstract][Full Text] [Related]
11. Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in spontaneously hypertensive and Wistar-Kyoto rats. Durand M; Aguerre S; Fernandez F; Edno L; Combourieu I; Mormède P; Chaouloff F Neuropharmacology; 2000 Sep; 39(12):2464-77. PubMed ID: 10974331 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. Yi LT; Li J; Liu Q; Geng D; Zhou YF; Ke XQ; Chen H; Weng LJ J Psychopharmacol; 2013 May; 27(5):459-68. PubMed ID: 23151611 [TBL] [Abstract][Full Text] [Related]
13. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy. Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337 [TBL] [Abstract][Full Text] [Related]
14. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat. Sterley TL; Howells FM; Russell VA Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064 [TBL] [Abstract][Full Text] [Related]
15. Antidepressant effects of resveratrol in an animal model of depression. Hurley LL; Akinfiresoye L; Kalejaiye O; Tizabi Y Behav Brain Res; 2014 Jul; 268():1-7. PubMed ID: 24717328 [TBL] [Abstract][Full Text] [Related]
16. Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? Lahmame A; del Arco C; Pazos A; Yritia M; Armario A Eur J Pharmacol; 1997 Oct; 337(2-3):115-23. PubMed ID: 9430405 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. Popik P; Krawczyk M; Golembiowska K; Nowak G; Janowsky A; Skolnick P; Lippa A; Basile AS Cell Mol Neurobiol; 2006; 26(4-6):857-73. PubMed ID: 16636898 [TBL] [Abstract][Full Text] [Related]
18. Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test. Finn DP; Martí O; Harbuz MS; Vallès A; Belda X; Márquez C; Jessop DS; Lalies MD; Armario A; Nutt DJ; Hudson AL Psychopharmacology (Berl); 2003 May; 167(2):195-202. PubMed ID: 12652345 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine. Rahman Z; Ring RH; Young K; Platt B; Lin Q; Schechter LE; Rosenzweig-Lipson S; Beyer CE Brain Res; 2008 Apr; 1203():68-78. PubMed ID: 18321472 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization and visualization of the glial serotonin transporter. Inazu M; Takeda H; Ikoshi H; Sugisawa M; Uchida Y; Matsumiya T Neurochem Int; 2001 Jul; 39(1):39-49. PubMed ID: 11311448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]